Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Data presented on circulating tumor cells in metastatic breast cancer
June 16th, 2005
Immunicon Corporation (IMMC) announced the presentation of further data from its clinical trial in metastatic breast cancer and the significance of circulating tumor cells (CTCs) in "non-measurable" disease. The abstract entitled: "Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC)," Abstract 503, was presented on May 14, 2005, by G. Thomas Budd, MD, of The Cleveland Clinic Foundation as an integrated education session at the 2005 Annual Meeting of the American Association of Clinical Oncology (ASCO). At the 2004 ASCO Annual Meeting and in the August 19, 2004, edition of The New England Journal of...
Source: Women's Health Weekly (2005-06-16)
|
